Given the data and tweets, could you project whether the closing price of $bmy will grow or shrink at 2017-07-03? Please specify either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-06-19,-1.4,0.3,-1.6,1.4,1.4,-1.2,-2.6,-2.5,-2.4,-2.2,-1.9
2017-06-20,-0.7,1.3,-1.0,0.8,0.8,-1.5,-2.6,-3.1,-3.0,-3.0,-2.6
2017-06-21,-0.6,0.9,-0.8,0.7,0.7,-1.7,-2.7,-3.5,-3.6,-3.5,-3.3
2017-06-22,-1.8,1.0,-2.1,2.2,2.2,-2.8,-4.1,-5.3,-5.4,-5.5,-5.3
2017-06-23,1.1,1.3,-0.7,-1.2,-1.2,-0.8,-2.4,-4.0,-4.0,-4.1,-4.0
2017-06-26,-0.4,0.6,-1.0,0.5,0.5,-0.7,-2.4,-3.9,-4.2,-4.4,-4.4
2017-06-27,1.6,1.7,-0.1,-1.8,-1.8,1.2,-0.4,-1.6,-2.3,-2.5,-2.6
2017-06-28,0.5,0.9,-0.2,-0.1,-0.1,1.2,-0.1,-1.2,-2.1,-2.3,-2.5
2017-06-29,0.2,0.6,-0.6,-0.1,-0.1,0.7,0.3,-0.8,-1.9,-2.1,-2.3
2017-06-30,0.5,0.6,-0.1,-0.2,-0.2,0.6,0.7,-0.3,-1.6,-1.8,-2.0

2017-06-19: rt AT_USER targeting the pd-1/pd-l1 immune checkpoint inegfr-mutated oralk-translocated nsclc $azn $mrk $bmy $rog $nvs |#bristolmyerssquibb bristol-myers squibb is poised for a breakout. read more:  $
2017-06-20: #bristolmyerssquibb bristolmyers squibb announces the pricing terms of its cash tender offer... read more:  $bmy|#bristolmyerssquibb bristolmyers squibb announces the pricing terms of its cash tender 
2017-06-21: biotechs blaze as trump draft order on drug pri... $ibb $pfe $mrk $bmy $nvs $lly $jnj $agn $amgn $biib $vrtx |biotechs blaze as trump draft order on drug pri... $ibb $pfe $mrk $bmy $nvs $lly $jnj $agn
2017-06-22: $ksu $bmy $spg $wb $acn $jack $pvh day trader setups traders live chatroom membership  #daytrading #tradingchatrooms|need help finding momentum stocks?   $htgm $jah $clr $dis $mo $bmy $pot $apa $cnq $
2017-06-23: get the latest ratings for $szmk $bned $ades $pwr $bmy in your inbox with marketbeat daily |AT_USER AT_USER analysis by #australia #biotechnology $nwbo collaborated with $bmy $mrk analyst¡­ |rt AT_USE
2017-06-24: rt AT_USER $bmy #bristol-myers squibb co. four-year follow-up with empliciti (elotuzumab) plus lenalidomide/dexametha... |$bmy #bristol-myers squibb co. four-year follow-up with empliciti (elotuzumab)
2017-06-25: analysts set bristol-myers squibb company $bmy target price at $61.62 |rt AT_USER $vdrm $frzt $chro $icnb $kerx $pfe $mrk $adxs $bmy $bac $c $gs $jpm $amd $dcth $csco $qqq $eled $nvax $mu $jd $ttd $an
2017-06-26: $0.74 earnings per share expected for bristol-myers squibb company $bmy this quarter |$0.74 earnings per share expected for bristol-myers squibb company $bmy this quarter |rt AT_USER $vdrm $frzt $chro
2017-06-27: #bristolmyerssquibb bristol-myers reports data on immuno-oncology drug empliciti. read more:  $bmy|#bristolmyerssquibb bristol-myers reports data on immuno-oncology drug empliciti. read more:  $bmy|rt
2017-06-28: rt AT_USER #mystic study success could put $azn ahead in #cancer revolution #biotech #pharma $mrk $rhhby $bmy  via¡­|rt AT_USER #mystic study success could put $azn ahead in #cancer revolution #biotec
2017-06-29: rt AT_USER AT_USER AT_USER AT_USER ceo you will want to speak linda powers AT_USER $nwbo about to shock #wa¡­|rt AT_USER AT_USER AT_USER AT_USER ceo you will want to speak linda powers AT_USER $nwbo a
2017-06-30: should we be interested in astrazeneca in 2017?  $azn $bmy $mrk $pfe|AT_USER AT_USER AT_USER imho $ptla gets taken out soon.  beyxxa was key approval. $pfe &amp; $bmy have¡­ |bristol-myers squibb comp
2017-07-01: rt AT_USER AT_USER AT_USER AT_USER don't see mystic positive or negative result a positive for $bmy. positive, one more io/io¡­|AT_USER AT_USER AT_USER as of $bmy share price, really depends on how mu
2017-07-02: benzinga: barron's picks and pans: bristol-myers, texas instruments, altaba and more  $aaba $bmy $ftr|barron's picks and pans: bristol-myers, texas instruments, altaba and more  $aaba $bmy $ftr|   cra
Answer:
Rise